we found a correlation between the percentage of CD14 expression on AML blasts and leukemic DC yield. 1, 2 However, in contrary to these authors, we were able to culture leukemic DC from CD14 À AML samples in 5/19 (26%) patients by the use of a conventional cytokine culture method. Moreover, this percentage could be further increased by the culture with calcium ionophores (CIs) in combination with IL-4. Mohty et al suggested that the leukemic DC derived from CD14
À AML samples, cultured in the presence of cytokines, could have been generated from expanded circulating peripheral blood myeloid dendritic cells (MDC), which do not express CD14. In all five described CD14 À AML cases, AML blasts were isolated from bone marrow aspirates. It seems unlikely that the high AML-DC yield in our experiments is solely explained by the presence of probably low numbers of MDC in bone marrow. In addition, in an allogeneic mixed leukocyte reaction (MLR) CD14 À AML samples showed little or no T-cell stimulating capacity as compared to their cultured CD14 --derived AML-DC. 3 On the contrary, Mohty et al 4 showed that freshly isolated peripheral blood MDC could efficiently induce proliferation of naive CD4 + T cells. 4 Our data indicate that the CD14 À , CD45 dim leukemic blasts are not likely to represent MDC. The use of CI, which bypasses receptormediated signaling, provides an interesting alternative culture method for the generation of AML-DC. 5 Culture in the presence of CI results in a more mature phenotype as compared to cytokinecultured AML-DC, as evidenced by an increased expression of CD40, CD54, CD83, and the costimulatory molecules CD80 and CD86. T cells primed with CI-cultured AML-DC showed high IFN-g production and no IL-4 and IL-10 as determined by ELISA, indicating a preferential Th1 response. 6 A predominantly Th1 profile could be confirmed by the increased production of IFN-g as determined by the intracellular staining of AML-DC primed T cells. No IL-4 was measured (manuscript in preparation). Autologous T-cell-mediated cytotoxicity towards AML blasts was evaluated by a recently developed flow-cytometric assay using Syto-16/7-AAD staining to detect early apoptosis and secondary necrosis. 7 In two patients tested, an increase in apoptosis and secondary necrosis was found after stimulation of autologous T cells with CI-cultured AML-DC as compared to unstimulated autologous T cells. 5 These results indicate that CI-cultured AML-DC are functionally active and are capable of inducing an autologous antileukemia response thereby providing a valuable alternative for the culture of AML-DC derived from CD14
À , as well as CD14 + , AML samples. 
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